Titan Bio-Tech Ltd.
TITANBIO · NSEon the next trading day
Valuation
Blended fair value using DCF and peer comparison methods.
See if Titan Bio-Tech Ltd. is undervalued
Unlock intrinsic value for 4,800+ Indian stocks — free.
Sign in or create free accountThe intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.
Peer comparison
How this company stacks up against sector peers on valuation and quality metrics.
Chemicals · 8 peers · sector medians shown
| Company | Mkt Cap | P/E | P/B | EV/EBITDA | ROE | Net Margin | Rev CAGR 3y |
|---|---|---|---|---|---|---|---|
Titan Bio-Tech Ltd. TITANBIO · you | ₹1,699 Cr | 55.3× | 12.3× | — | 22.4% | 0.2% | — |
| Sector median | — | 54.7× | 3.4× | 28.2× | 11.7% | 2.7% | 5.5% |
| Sudeep Pharma Limited SUDEEPPHRM | ₹12,509 Cr | 107.6× | — | — | — | 0.3% | — |
| Alkyl Amines Chemicals Limited ALKYLAMINE | ₹10,444 Cr | 54.7× | 6.4× | 35.8× | 11.7% | 11.7% | -3.0% |
| Elantas Beck India Limited ELANTAS | ₹9,065 Cr | 61.8× | 9.1× | 48.4× | 14.7% | 17.4% | 9.6% |
| Sudarshan Chemical Industries Limited SUDARSCHEM | ₹8,698 Cr | 314.9× | 2.0× | 19.0× | 0.7% | 0.2% | 62.0% |
| Galaxy Surfactants Limited GALAXYSURF | ₹8,112 Cr | 27.8× | 2.7× | 16.2× | 9.7% | 5.1% | 5.5% |
| Balaji Amines Limited BALAMINES | ₹7,745 Cr | 40.6× | 3.4× | 28.2× | 8.5% | 11.7% | -15.4% |
| TANFAC Industries Ltd. TANFACIND | ₹7,518 Cr | 111.2× | 28.8× | — | 25.9% | 0.1% | — |
| Sharda Cropchem Limited SHARDACROP | ₹7,103 Cr | 10.1× | 3.4× | — | 33.4% | 0.1% | — |
Titan is fairly valued relative to sector peers — trading near the sector median on key multiples (P/E ~54.7×, EV/EBITDA ~28.2×). Focus on execution quality and earnings trajectory from here.
Business quality
Valuation
Returns
Growth
Efficiency
Liquidity & Solvency
Financial health
Piotroski F-Score, Altman Z-Score, and key solvency ratios.
Full financial data
Charts and annual statements for income, balance sheet and cash flow.
Income trend
Revenue, profit and margin trends over time.
Cash flow
Where cash comes from and where it goes.
Balance sheet
Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.